Overview
A planned quantum-chip fabrication and testing facility at 770 Broadway in Manhattan, announced 14 October 2026 by New York City Mayor Zohran Mamdani and NYU. Funded by $284 million total, a $29.2 million New York City grant plus a $255 million NYU commitment covering construction and the first 10 years of operations. The 23,000-square-foot facility will house specialized cleanrooms and cryogenic testbeds to fabricate, test, and prototype quantum chips and components, serving NYU/CUNY researchers and outside startups and companies; it is expected to open in 2030 and, over its first decade, aims to incubate roughly 50 startups and serve 50 additional companies. Structured as a first-of-its-kind public-equity partnership: the City of New York holds 3 seats on the facility's Executive Advisory Board and a 15% share of IP proceeds generated using city-funded equipment. Key facility details include: The facility is situated at 770 Broadway, New York, NY, USA. It focuses on Research, Pilot Line. This site represents an estimated investment of $0.284B. Production at this facility is expected to begin in 2030.